Загрузка...
Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis
INTRODUCTION: This meta-analysis compares the effectiveness and safety of tumor necrosis factor α (TNF-α) antibodies (infliximab, adalimumab and certolizumab) with either a placebo or each of them in the treatment of Crohn's disease (CD). MATERIAL AND METHODS: A systematic review of literature...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Termedia Publishing House
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3832823/ https://ncbi.nlm.nih.gov/pubmed/24273556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2013.38670 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|